Smart for Life (NASDAQ:SMFL – Get Rating) and biote (NASDAQ:BTMD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.
Earnings & Valuation
This table compares Smart for Life and biote's gross revenue, earnings per share and valuation.
Get Smart for Life alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smart for Life | $9.02 million | 0.80 | -$7.77 million | N/A | N/A |
| biote | N/A | N/A | $11.11 million | N/A | N/A |
biote has lower revenue, but higher earnings than Smart for Life.
Institutional and Insider Ownership
0.4% of Smart for Life shares are held by institutional investors. Comparatively, 3.8% of biote shares are held by institutional investors. 45.1% of Smart for Life shares are held by company insiders. Comparatively, 20.0% of biote shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.Profitability
This table compares Smart for Life and biote's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Smart for Life | -139.56% | -1,377.59% | -94.78% |
| biote | N/A | -20.05% | 5.99% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Smart for Life and biote, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
| biote | 0 | 0 | 4 | 0 | 3.00 |
Smart for Life presently has a consensus target price of $8.00, suggesting a potential upside of 3,897.98%. biote has a consensus target price of $10.25, suggesting a potential upside of 115.79%. Given Smart for Life's higher possible upside, research analysts plainly believe Smart for Life is more favorable than biote.
Summary
biote beats Smart for Life on 6 of the 9 factors compared between the two stocks.
About Smart for Life
(Get Rating)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
About biote
(Get Rating)
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Receive News & Ratings for Smart for Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smart for Life and related companies with MarketBeat.com's FREE daily email newsletter.